Cryoablation Combined with Sintilimab Plus Lenvatinib in Previously Treated Unresectable Liver Metastasis from Solid Tumors

NCT05098847 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Liver Metastasis

Interventions

DRUG: Sintilimab
DRUG: Lenvatinib
DRUG: Cryoablation

Sponsor

Fudan University